Effects of chronic heart failure on neuronal nitric oxide synthase-mediated control of microvascular O 2 pressure in contracting rat skeletal muscle

Journal of Physiology

Volumn 590, Issue 15, 2012, Pages 3585-3596

  Copp, Steven W ^a   Hirai, Daniel M ^a   Ferguson, Scott K ^a   Holdsworth, Clark T ^a   Musch, Timothy I ^a   Poole, David C ^a  

^a KANSAS STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; NEURONAL NITRIC OXIDE SYNTHASE; OXYGEN; S METHYLTHIOCITRULLINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; ENZYME INHIBITION; ENZYME REGULATION; HEART FAILURE; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; MALE; MICROVASCULAR OXYGEN TENSION; MUSCLE BLOOD FLOW; MUSCLE CONTRACTION; NONHUMAN; OXYGEN TENSION; PHOTOCHEMICAL QUENCHING; PRIORITY JOURNAL; RAT; REGULATORY MECHANISM; RESPONSE TIME; STEADY STATE; TRAPEZIUS MUSCLE;

EID: 84864310469     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/jphysiol.2012.235929     Document Type: Article

References (50)

1. Altman P & Dittmer D (1974). Biological Data Book, 2nd edn. FASEB, Bethesda, MD.
2. Bailey JK, Kindig CA, Behnke BJ, Musch TI, Schmid-Schoenbein GW & Poole DC (2000). Spinotrapezius muscle microcirculatory function: effects of surgical exteriorization. Am J Physiol Heart Circ Physiol 279, H3131-3137.
3. 2 cost of force development and spares high-energy phosphates following contractions in pump-perfused rat hindlimb muscles. Exp Physiol 91, 581-589.
4. Behnke BJ, Delp MD, McDonough P, Spier SA, Poole DC & Musch TI (2004). Effects of chronic heart failure on microvascular oxygen exchange dynamics in muscles of contrasting fiber type. Cardiovasc Res 61, 325-332.
5. Bertaglia RS, Reissler J, Lopes FS, Cavalcante WL, Carani FR, Padovani CR, Rodrigues SA, Cigogna AC, Carvalho RF, Fernandes AA, Gallacci M & Silva MD (2011). Differential morphofunctional characteristics and gene expression in fast and slow muscle of rats with monocrotaline-induced heart failure. J Mol Histol 42, 205-215.
6. Brown GC (1995). Nitric oxide regulates mitochondrial respiration and cell functions by inhibiting cytochrome oxidase. FEBS letters 369, 136-139.
7. Copp SW, Hirai DM, Ferguson SK, Musch TI & Poole DC (2011). Role of neuronal nitric oxide synthase in modulating microvascular and contractile function in rat skeletal muscle. Microcirculation 18, 501-511.
8. 2 pressures after contractions in the rat spinotrapezius muscle. Am J Physiol Heart Circ Physiol 299, H1755-1761.
9. Copp SW, Hirai DM, Schwagerl PJ, Musch TI & Poole DC (2010b). Effects of neuronal nitric oxide synthase inhibition on resting and exercising hindlimb muscle blood flow in the rat. J Physiol 588, 1321-1331.
10. Delp MD, Duan C, Mattson JP & Musch TI (1997). Changes in skeletal muscle biochemistry and histology relative to fiber type in rats with heart failure. J Appl Physiol 83, 1291-1299.
11. Diederich ER, Behnke BJ, McDonough P, Kindig CA, Barstow TJ, Poole DC & Musch TI (2002). Dynamics of microvascular oxygen partial pressure in contracting skeletal muscle of rats with chronic heart failure. Cardiovasc Res 56, 479-486.
12. Drummond GB (2009). Reporting ethical matters in The Journal of Physiology: standards and advice. J Physiol 587, 713-719.
13. Ertunc M, Sara Y, Korkusuz P & Onur R (2009). Differential contractile impairment of fast- and slow-twitch skeletal muscles in a rat model of doxorubicin-induced congestive heart failure. Pharmacology 84, 240-248.
14. Feng Q, Lu X, Fortin AJ, Pettersson A, Hedner T, Kline RL & Arnold JM (1998). Elevation of an endogenous inhibitor of nitric oxide synthesis in experimental congestive heart failure. Cardiovasc Res 37, 667-675.
15. Ferreira LF, Hageman KS, Hahn SA, Williams J, Padilla DJ, Poole DC & Musch TI (2006a). Muscle microvascular oxygenation in chronic heart failure: role of nitric oxide availability. Acta Physiologica 188, 3-13.
16. Ferreira LF, Padilla DJ, Williams J, Hageman KS, Musch TI & Poole DC (2006b). Effects of altered nitric oxide availability on rat muscle microvascular oxygenation during contractions. Acta Physiol (Oxf) 186, 223-232.
17. Furfine ES, Harmon MF, Paith JE, Knowles RG, Salter M, Kiff RJ, Duffy C, Hazelwood R, Oplinger JA & Garvey EP (1994). Potent and selective inhibition of human nitric oxide synthases. Selective inhibition of neuronal nitric oxide synthase by S-methyl-L-thiocitrulline and S-ethyl-L-thiocitrulline. J Biol Chem 269, 26677-26683.
18. Hambrecht R, Adams V, Gielen S, Linke A, Mobius-Winkler S, Yu J, Niebauer J, Jiang H, Fiehn E & Schuler G (1999). Exercise intolerance in patients with chronic heart failure and increased expression of inducible nitric oxide synthase in the skeletal muscle. J Am Coll Cardiol 33, 174-179.
19. Hirai DM, Copp SW, Ferreira LF, Musch TI & Poole DC (2010). Nitric oxide bioavailability modulates the dynamics of microvascular oxygen exchange during recovery from contractions. Acta Physiol (Oxf) 200, 159-169.
20. Hirai T, Zelis R & Musch TI (1995). Effects of nitric oxide synthase inhibition on the muscle blood flow response to exercise in rats with heart failure. Cardiovasc Res 30, 469-476.
21. Ichihara A, Inscho EW, Imig JD & Navar LG (1998). Neuronal nitric oxide synthase modulates rat renal microvascular function. Am J Physiol Renal Physiol 274, F516-524.
22. Ishise S, Pegram BL, Yamamoto J, Kitamura Y & Frohlich ED (1980). Reference sample microsphere method: cardiac output and blood flows in conscious rat. Am J Physiol Heart Circ Physiol 239, H443-H449.
23. Kaiser L, Spickard RC & Olivier NB (1989). Heart failure depresses endothelium-dependent responses in canine femoral artery. Am J Physiol Heart Circ Physiol 256, H962-967.
24. Katz SD, Biasucci L, Sabba C, Strom JA, Jondeau G, Galvao M, Solomon S, Nikolic SD, Forman R & LeJemtel TH (1992). Impaired endothelium-mediated vasodilation in the peripheral vasculature of patients with congestive heart failure. J Am Coll Cardiol 19, 918-925.
25. Katz SD, Krum H, Khan T & Knecht M (1996). Exercise-induced vasodilation in forearm circulation of normal subjects and patients with congestive heart failure: role of endothelium-derived nitric oxide. J Am Coll Cardiol 28, 585-590.
26. Komers R, Oyama TT, Chapman JG, Allison KM & Anderson S (2000). Effects of systemic inhibition of neuronal nitric oxide synthase in diabetic rats. Hypertension 35, 655-661.
27. 2 delivery. Exp Physiol 90, 889-900.
28. Landmesser U, Spiekermann S, Dikalov S, Tatge H, Wilke R, Kohler C, Harrison DG, Hornig B & Drexler H (2002). Vascular oxidative stress and endothelial dysfunction in patients with chronic heart failure: role of xanthine-oxidase and extracellular superoxide dismutase. Circulation 106, 3073-3078.
29. Lo LW, Vinogradov SA, Koch CJ & Wilson DF (1997). A new, water soluble, phosphor for oxygen measurements in vivo. Adv Ex Med Biol 428, 651-656.
30. Longhurst J, Gifford W & Zelis R (1976). Impaired forearm oxygen consumption during static exercise in patients with congestive heart failure. Circulation 54, 477-480.
31. Lunde PK, Verburg E, Eriksen M & Sejersted OM (2002). Contractile properties of in situ perfused skeletal muscles from rats with congestive heart failure. J Physiol 540, 571-580.
32. Massie B, Conway M, Yonge R, Frostick S, Ledingham J, Sleight P, Radda G & Rajagopalan B (1987). Skeletal muscle metabolism in patients with congestive heart failure: relation to clinical severity and blood flow. Circulation 76, 1009-1019.
33. Munzel T, Daiber A, Ullrich V & Mulsch A (2005). Vascular consequences of endothelial nitric oxide synthase uncoupling for the activity and expression of the soluble guanylyl cyclase and the cGMP-dependent protein kinase. Arterioscler Thromb Vasc Biol 25, 1551-1557.
34. Musch TI & Terrell JA (1992). Skeletal muscle blood flow abnormalities in rats with a chronic myocardial infarction: rest and exercise. Am J Physiol Heart Circ Physiol 262, H411-419.
35. Nicoletti I, Cicoira M, Zanolla L, Franceschini L, Brighetti G, Pilati M & Zardini P (2003). Skeletal muscle abnormalities in chronic heart failure patients: relation to exercise capacity and therapeutic implications. Congest Heart Fail 9, 148-154.
36. 2+ transients in isolated bundles of skeletal muscle fibers from rats with chronic heart failure. Circ Res 73, 405-412.
37. Poole DC, Behnke BJ, McDonough P, McAllister RM & Wilson DF (2004). Measurement of muscle microvascular oxygen pressures: compartmentalization of phosphorescent probe. Microcirculation 11, 317-326.
38. Poole DC, Hirai DM, Copp SW & Musch TI (2012). Muscle oxygen transport and utilization in heart failure: implications for exercise (in)tolerance. Am J Physiol Heart Circ Physiol 302, H1050-1063.
39. Reid MB, Kobzik L, Bredt DS & Stamler JS (1998). Nitric oxide modulates excitation-contraction coupling in the diaphragm. Comp Biochem Physiol 119, 211-218.
40. Reiken S, Lacampagne A, Zhou H, Kherani A, Lehnart SE, Ward C, Huang F, Gaburjakova M, Gaburjakova J, Rosemblit N, Warren MS, He KL, Yi GH, Wang J, Burkhoff D, Vassort G & Marks AR (2003). PKA phosphorylation activates the calcium release channel (ryanodine receptor) in skeletal muscle: defective regulation in heart failure. J Cell Biol 160, 919-928.
41. Rumsey WL, Vanderkooi JM & Wilson DF (1988). Imaging of phosphorescence: a novel method for measuring oxygen distribution in perfused tissue. Science 241, 1649-1651.
42. Rush JW, Green HJ, Maclean DA & Code LM (2005). Oxidative stress and nitric oxide synthase in skeletal muscles of rats with post-infarction, compensated chronic heart failure. Acta Physiol Scand 185, 211-218.
43. Seddon M, Looi YH & Shah AM (2007). Oxidative stress and redox signalling in cardiac hypertrophy and heart failure. Heart 93, 903-907.
44. Seddon M, Melikian N, Dworakowski R, Shabeeh H, Jiang B, Byrne J, Casadei B, Chowienczyk P & Shah AM (2009). Effects of neuronal nitric oxide synthase on human coronary artery diameter and blood flow in vivo. Circulation 119, 2656-2662.
45. Seddon MD, Chowienczyk PJ, Brett SE, Casadei B & Shah AM (2008). Neuronal nitric oxide synthase regulates basal microvascular tone in humans in vivo. Circulation 117, 1991-1996.
46. Symons JD, Stebbins CL & Musch TI (1999). Interactions between angiotensin II and nitric oxide during exercise in normal and heart failure rats. J Appl Physiol 87, 574-581.
47. Thomas GD, Sander M, Lau KS, Huang PL, Stull JT & Victor RG (1998). Impaired metabolic modulation of α-adrenergic vasoconstriction in dystrophin-deficient skeletal muscle. Proc Natl Acad Sci U S A 95, 15090-15095.
48. Thomas GD, Zhang W & Victor RG (2001). Impaired modulation of sympathetic vasoconstriction in contracting skeletal muscle of rats with chronic myocardial infarctions: role of oxidative stress. Circ Res 88, 816-823.
49. Usui M, Matsuoka H, Miyazaki H, Ueda S, Okuda S & Imaizumi T (1998). Increased endogenous nitric oxide synthase inhibitor in patients with congestive heart failure. Life Sci 62, 2425-2430.
50. Wakefield ID, March JE, Kemp PA, Valentin JP, Bennett T & Gardiner SM (2003). Comparative regional haemodynamic effects of the nitric oxide synthase inhibitors, S-methyl-L-thiocitrulline and L-NAME, in conscious rats. Br J Pharmacol 139, 1235-1243.